Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies

J Thromb Haemost. 2007 Apr;5(4):866-7. doi: 10.1111/j.1538-7836.2007.02438.x.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins / metabolism
  • ADAM Proteins / physiology*
  • ADAMTS13 Protein
  • Acute Disease
  • Bilirubin / chemistry
  • Chemistry, Clinical / methods
  • Hematologic Diseases / complications
  • Hematologic Diseases / diagnosis
  • Humans
  • Hyperbilirubinemia / blood*
  • Hyperbilirubinemia / complications
  • Hyperbilirubinemia / pathology
  • Kinetics
  • Purpura, Thrombotic Thrombocytopenic / blood
  • Purpura, Thrombotic Thrombocytopenic / diagnosis*
  • Reproducibility of Results
  • Time Factors
  • von Willebrand Factor / biosynthesis*

Substances

  • von Willebrand Factor
  • ADAM Proteins
  • ADAMTS13 Protein
  • ADAMTS13 protein, human
  • Bilirubin